North America Transfection Reagents and Equipment Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Product (Reagents and Instruments), Method (Viral Methods, Non-Viral Methods, and Hybrid Methods), Application (Biomedical Research, Protein Production, and Therapeutic Delivery), and End User (Academics & Research Institutes and Pharmaceutical & Biotechnology Companies)

No. of Pages: 108    |    Report Code: BMIRE00030528    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Transfection Reagents and Equipment Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Transfection Reagents and Equipment Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Transfection Reagents and Equipment Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increasing Popularity of Cell and Gene Therapy
  • 5.1.2 Growing Economic Burden of Cancer
5.2 Market Opportunities
  • 5.2.1 Ramping Up Small Scale
  • 5.2.2 Processes to Large Scale Processes
5.3 Future Trends
  • 5.3.1 Strategic Initiatives By Companies
5.4 Impact of Drivers and Restraints

6. North America Transfection Reagents and Equipment Market Regional Analysis

6.1 North America Transfection Reagents and Equipment Market Overview
6.2 North America Transfection Reagents and Equipment Market Revenue 2020-2030 (US$ Million)
6.3 North America Transfection Reagents and Equipment Market Forecast Analysis

7. North America Transfection Reagents and Equipment Market Analysis – by Product

7.1 Reagents and Instruments
  • 7.1.1 Overview
  • 7.1.2 Reagents and Instruments: North America Transfection Reagents and Equipment Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Transfection Reagents and Equipment Market Analysis – by Method

8.1 Viral Methods
  • 8.1.1 Overview
  • 8.1.2 Viral Methods: North America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Non-Viral Methods
  • 8.2.1 Overview
  • 8.2.2 Non-Viral Methods: North America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Hybrid Methods
  • 8.3.1 Overview
  • 8.3.2 Hybrid Methods: North America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)

9. North America Transfection Reagents and Equipment Market Analysis – by End User

9.1 Academics & Research Institutes and Pharmaceutical & Biotechnology Companies
  • 9.1.1 Overview
  • 9.1.2 Hybrid Methods: North America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)

10. North America Transfection Reagents and Equipment Market – North America Analysis

10.1 North America
  • 10.1.1 North America Transfection Reagents and Equipment Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 10.1.1.1 North America Transfection Reagents and Equipment Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.1.1 US: North America Transfection Reagents and Equipment Market Breakdown, by Product
    • 10.1.1.1.2 US: North America Transfection Reagents and Equipment Market Breakdown, by Method
    • 10.1.1.1.3 US: North America Transfection Reagents and Equipment Market Breakdown, by End User
  • 10.1.1.2 Canada: North America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.2.1 Canada: North America Transfection Reagents and Equipment Market Breakdown, by Product
    • 10.1.1.2.2 Canada: North America Transfection Reagents and Equipment Market Breakdown, by Method
    • 10.1.1.2.3 Canada: North America Transfection Reagents and Equipment Market Breakdown, by End User
  • 10.1.1.3 Mexico : North America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Transfection Reagents and Equipment Market Breakdown, by Product
    • 10.1.1.3.2 Mexico : North America Transfection Reagents and Equipment Market Breakdown, by Method
    • 10.1.1.3.3 Mexico : North America Transfection Reagents and Equipment Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Transfection Reagents and Equipment Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Thermo Fisher Scientific Inc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Promega Corp
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 F. Hoffmann-La Roche Ltd
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Bio-Rad Laboratories Inc
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Mirus Bio LLC
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 QIAGEN NV
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Merck KGaA
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Lonza Group AG
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 MaxCyte Inc
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Polyplus-Transfection SA
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - N Market

1. Thermo Fisher Scientific Inc
2. Promega Corp
3. F. Hoffmann-La Roche Ltd
4. Bio-Rad Laboratories Inc
5. Mirus Bio LLC
6. QIAGEN NV
7. Merck KGaA
8. Lonza Group AG
9. MaxCyte Inc
10. Polyplus-Transfection SA

north-america-transfection-reagents-and-equipment-market